Closed for maternity leave 3 May – 27 September 2026. Responding to emails and WhatsApp with some delay.
Evidence-based myopia management articles from Dr Carina Trinh at Carina Eye Care.
A side-by-side look at the published clinical trial results behind MiYOSMART, Stellest, DOT, MyoCare, MyCon and other myopia control spectacle lenses for children.
An optometrist's overview of SightGlass DOT contrast-management lenses for childhood myopia control: how they work, the clinical evidence, where they're available, and how they compare to MiyoSmart iQ and Stellest 2.0.
Essilor's Stellest 2.0 and Hoya's MiYOSMART iQ are the next generation of myopia control spectacle lenses. What's actually changed, and what the results show.
A 2021 study found smaller back optic zone diameters (BOZD) in orthokeratology lenses produced 76% less axial length growth. What this means for your child.
An evidence-based comparison of EssilorLuxottica Stellest and Hoya MiyoSmart lenses for myopia management: how they're similar, how they differ.
Atropine eye drops can slow myopia progression in children by up to 60%. Learn how they work, what concentrations are used, and what parents need to know.
